(Manila Bulletin File Photo)
DOST-PCHRD Executive Director Dr. Jaime C. Montoya noted that the Philippines had participated in the WHO Solidarity Treatment Trial of four repurposed antiviral drugs Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon beta-1a.
“Natapos na po ang ating participation sa WHO Solidarity Treatment Trial at tiningnan po ang apat na repurposed drugs kung sila ay makakatulong sa mga pasyenteng may COVID 19 kaya lang po base sa datos at analysis ng WHO dun sa mga datos na nakuha from the Philippines at sa ibang bansa ay mukhang wala po sa apat na repurposed drugs na ito ang makakatulong (Our participation in the WHO Solidarity Treatment Trial has ended and we have looked at four repurposed drugs if they can help patients with COVID 19, but based on WHO data and analysis of data obtained from the Philippines and other countries it seems that none of these four repurposed drugs can help),” he said during the Laging Handa briefing.